Home › Free Stock Grades › SPRY
ARS Pharmaceuticals, Inc. (SPRY) Stock Grade
SPRY · Healthcare
C-
Market Cap
$1.1B
P/E Ratio
—
Revenue Growth (YoY)
-5.5%
Net Margin
-203.3%
Return on Equity
—
Dividend Yield
None
About ARS Pharmaceuticals, Inc.'s fundamentals
ARS Pharmaceuticals is a biotechnology company with a market capitalization of $1.1 billion that reported a net loss in its latest annual statement, reflected in its negative net margin of -203.3%. The company experienced a year-over-year revenue decline of 5.5%, indicating contraction in sales during the period. As a loss-making biotech firm, the company does not pay a dividend and traditional profitability metrics like price-to-earnings ratio and return on equity are not applicable.